All drugs are monitored rigidly, even after having been approved by FDA, for reported adverse effects and drug interactions. It is duty of every practitioner to report – both to the manufacturer and FDA – any unreported adverse effect (maybe in one patient) for rational monitoring and necessary action. Team@CMHF